TOP

Press Releases

You can read it in the journals and newspapers, or you can read it here first. Please check back frequently to see where the future is headed, compliments of Sequenom.

November 2014

Nov 25, 2014 SAN DIEGO, Nov. 25, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York, NY on December 2-3, 2014. William Welch, Chief Executive Officer will participate in a Fireside Chat Presentation on Wednesday, December 3, beginning at 8:30 a.m. ET to provide an overview of and update on... Read more
- 14% increase in revenue from the prior year third quarter - 50% increase in gross margin to 45% in the quarter from the prior year third quarter - Net loss of $6.1 million, or $0.05 per share in the quarter compared to $28.1 million, or $0.24 in the prior year third quarter - Cash used in operating activities of $3.8 million, down from $21.9 million in the prior year third quarter Nov 4, 2014 SAN DIEGO, Nov. 4, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company... Read more

October 2014

Oct 21, 2014 SAN DIEGO, Oct. 21, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it will report financial results for the third quarter 2014 after closing of the NASDAQ Global Market on Tuesday, November 4, 2014.   A conference call hosted by William Welch, CEO, and other members of senior management will take place on Tuesday, November 4, 2014, at 5:00 p.m. EDT (2:00 p.m. PDT) and will be webcast live... Read more
Oct 6, 2014 SAN DIEGO and OXFORD, England, Oct. 6, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions and Isis Innovation Ltd., the technology transfer company of the University of Oxford, today jointly announced that Sequenom has purchased noninvasive prenatal testing intellectual property from Isis Innovation, for $14.55 million, which includes $3.2 million as the final royalty payment due to Isis under the prior... Read more

September 2014

Sep 22, 2014 SAN DIEGO, Sept. 22, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that its wholly owned subsidiary, Sequenom Laboratories, presented patient clinical data substantiating the performance of its MaterniT21® PLUS noninvasive prenatal test (NIPT) in the laboratory. An ad hoc analysis of 185,000 samples from patients at high-risk for fetal chromosome aneuploidy demonstrated stable positivity... Read more
Sep 2, 2014 SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York, NY on September 8 -10, 2014. William Welch, Chief Executive Officer, and Carolyn Beaver, Chief Financial Officer, will present on Monday, September 8, beginning at 9:20 a.m. ET to provide an overview of and... Read more

Pages